Neil M. Iyengar, MD, on Testing for ESR1 Mutations in ER-Positive Breast Cancer
Neil M. Iyengar, MD, on Testing for ESR1 Mutations in ER-Positive Breast Cancer The ASCO Post
Neil M. Iyengar, MD, on Testing for ESR1 Mutations in ER-Positive Breast Cancer The ASCO Post
Neil M. Iyengar, MD, on Co-Occurring Mutations in Advanced Breast Cancer: Management Strategies The ASCO Post
Жители Грушевцев прошли бесплатные скрининги на онкологию и инфекции BUK Media
BMS gains two pivotal trial wins in lung disease and rare cancer Clinical Trials Arena
Mantle Cell Lymphoma Guidelines Let Some Patients Skip Transplant Cure Today
Igor Štagljar, a renowned scientist who is pushing the boundaries of cancer research: Investing in science is an investment in the future. vijesti.me
Израильские ученые обнаружили механизм, позволяющий раковым клеткам выживать после химиотерапии Лехаим
A research team led by professor Chan Kui-ming from the Department of Biomedical Sciences at CityUHK discovered that H2BE113K, a missense H2B mutation, promotes colony formation and lung metastasis in breast cancer. The research revealed that H2BE113K plays a critical role in chromatin regulation, cellular function…
From Liquid Biopsy to New Treatment Modalities: What to Expect at Northeast GI Oncology Congress 2026 Oncodaily
На Южном Урале опровергли мифы о раке молочной железы https://zur-chelyabinsk.ru/
6 Diet Changes To Lower Your Risk of Breast Cancer, According to an Oncology Nurse AOL.com
New Tumor State Helps Identify High-Risk Small-Cell Lung Cancer Northwestern University
Рентгенолог из Тулы объяснил пользу ИИ при диагностике рака молочной железы Первый Тульский